|
Apr 29
|
RINVOQ® (upadacitinib) Receives U.S. FDA Approval for Giant Cell Arteritis (GCA)
|
|
Apr 29
|
United Therapeutics (UTHR) To Report Earnings Tomorrow: Here Is What To Expect
|
|
Apr 28
|
Why AbbVie Stock Trounced the Market Today
|
|
Apr 28
|
S&P 500 Gains and Losses Today: AbbVie Stock Advances After Beat-and-Raise Earnings Report
|
|
Apr 26
|
4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off
|
|
Apr 26
|
China weighs U.S. tariff exemptions, Alphabet reports Q1 beat: Morning Buzz
|
|
Apr 26
|
AbbVie Inc (ABBV) Q1 2025 Earnings Call Highlights: Strong Growth in Immunology and ...
|
|
Apr 26
|
Q1 2025 AbbVie Inc Earnings Call
|
|
Apr 26
|
How Much Would It Take To Earn $100 A Month From AbbVie Stock
|
|
Apr 25
|
Why AbbVie Stock Topped the Market Today
|
|
Apr 25
|
Is AbbVie Inc. (ABBV) the Best Dividend Stock to Buy for Long-Term Passive Income?
|
|
Apr 25
|
AbbVie Hikes Its Outlook On The Back Of Two Powerhouse Drugs
|
|
Apr 25
|
AbbVie (NYSE:ABBV) Reports US$13 Billion Sales, Submits Application For New Neurotoxin
|
|
Apr 25
|
AbbVie Beats on Q1 Earnings & Sales, Raises '25 EPS View
|
|
Apr 25
|
Bitcoin extends rally, AbbVie earnings beat, Phillips 66 miss
|
|
Apr 25
|
AbbVie Stock Rises on Stronger-Than-Expected Results, Profit Outlook Lift
|
|
Apr 25
|
AbbVie Stock Rises Despite Risks as Earnings Beat Forecasts
|
|
Apr 25
|
Drugmaker Abbvie Ramps Up Domestic Manufacturing Plans on Tariff Threats
|
|
Apr 25
|
AbbVie warns of tariff exposure, U.S. policy risks while boosting forecast
|
|
Apr 25
|
AbbVie Raises Full-Year Outlook as First-Quarter Results Top Street Estimates
|